Literature DB >> 24955153

miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinoma.

Xi Chen1, Juan Wang2, Lei Cheng1, Mei-Ping Lu1.   

Abstract

Nasopharyngeal carcinoma, common in Southeast Asia and the southern provinces of China, often has metastasized by the time of diagnosis; thus there exists the need for improved diagnosis and treatment. Accumulating evidence indicates that microRNAs (miRNAs), which post-transcriptionally regulate protein expression, contribute to the processes of tumorigenesis, including metastasis and cellular invasion. Here, we studied the effect of one miRNA, miR-18a-which is believed to target the miRNA-processing enzyme DICERl-on nasopharyngeal carcinoma. In situ hybridization revealed that miR-18a was more highly expressed in nasopharyngeal carcinoma tissues than in control tissues (P < 0.05), and the overexpression correlated with clinical stage and lymph node metastasis (P < 0.05), but not with age and gender (P > 0.05). In vitro analysis of HK1 nasopharyngeal carcinoma cells transfected with miR-18a exhibited significantly decreased expression of DICER1 mRNA and protein but significantly increased proliferation and invasion properties compared to control cells (P < 0.05). Finally, nude mice injected with miR-18a transfected-HK1 cells displayed significantly increased tumor growth and lung metastasis in vivo (P < 0.05). These findings suggest that miR-18a expression can promote proliferation and metastasis of nasopharyngeal carcinoma cells and that these activities may occur through its regulation of DICER1.

Entities:  

Keywords:  Dicer1; HK1 cells; Nasopharyngeal carcinoma; metastasis; microRNA-18a; proliferation

Year:  2014        PMID: 24955153      PMCID: PMC4057832     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  26 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review.

Authors:  Wei-Hua Jia; Hai-De Qin
Journal:  Semin Cancer Biol       Date:  2012-01-30       Impact factor: 15.707

3.  The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.

Authors:  Xiaofang Guo; Qianjin Liao; Pan Chen; Xiayu Li; Wei Xiong; Jian Ma; Xiaoling Li; Zhaohui Luo; Hailin Tang; Min Deng; Yin Zheng; Rong Wang; Wenling Zhang; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-28       Impact factor: 4.553

Review 4.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

5.  Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.

Authors:  Xiaohui Xie; Jun Lu; E J Kulbokas; Todd R Golub; Vamsi Mootha; Kerstin Lindblad-Toh; Eric S Lander; Manolis Kellis
Journal:  Nature       Date:  2005-02-27       Impact factor: 49.962

6.  A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.

Authors:  Elisavet Maniataki; Zissimos Mourelatos
Journal:  Genes Dev       Date:  2005-12-15       Impact factor: 11.361

7.  microRNA evaluation of unknown primary lesions in the head and neck.

Authors:  Emma V Barker; Nilva K Cervigne; Patricia P Reis; Rashmi S Goswami; Wei Xu; Ilan Weinreb; Jonathan C Irish; Suzanne Kamel-Reid
Journal:  Mol Cancer       Date:  2009-12-23       Impact factor: 27.401

8.  The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.

Authors:  Wing Pui Tsang; Tim Tak Kwok
Journal:  Carcinogenesis       Date:  2009-04-16       Impact factor: 4.944

9.  Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer.

Authors:  R Morimura; S Komatsu; D Ichikawa; H Takeshita; M Tsujiura; H Nagata; H Konishi; A Shiozaki; H Ikoma; K Okamoto; T Ochiai; H Taniguchi; E Otsuji
Journal:  Br J Cancer       Date:  2011-11-01       Impact factor: 7.640

10.  MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.

Authors:  B Diosdado; M A van de Wiel; J S Terhaar Sive Droste; S Mongera; C Postma; W J H J Meijerink; B Carvalho; G A Meijer
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more
  6 in total

1.  The Effect of (E)-1-(4'-aminophenyl)-3-phenylprop-2-en-1-one on MicroRNA-18a, Dicer1, and MMP-9 Expressions against DMBA-Induced Breast Cancer.

Authors:  Ida Ayu Ika Wahyuniari; I Gusti Kamasan Nyoman Arijana; Ni Putu Sriwidyani; Hery Suwito; Sitarina Widyarini; Muhammad Ghufron; Mustofa Mustofa; Sofia Mubarika Haryana
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

2.  Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.

Authors:  Yankun Zhang; Wei Qian; Feng Feng; Qian Cao; Yanqi Li; Ying Hou; Luyang Zhang; Jufeng Fan
Journal:  Oncol Res       Date:  2018-02-08       Impact factor: 5.574

3.  Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.

Authors:  Chunyu Huang; Shuiying Tang; Dong Shen; Xiangzhao Li; Li Liang; Yanqing Ding; Bihong Xu
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

4.  Tumor-Educated Platelet miR-18a-3p as a Novel Liquid-Biopsy Biomarker for Early Diagnosis and Chemotherapy Efficacy Monitoring in Nasopharyngeal Carcinoma.

Authors:  Kaiyu Sun; Hui Wang; Xianqun Xu; Xiuqi Wei; Jingyu Su; Kaidong Zhu; Junli Fan
Journal:  Front Oncol       Date:  2021-10-06       Impact factor: 6.244

5.  MicroRNA-18a promotes cancer progression through SMG1 suppression and mTOR pathway activation in nasopharyngeal carcinoma.

Authors:  ShiJuan Mai; RuoWen Xiao; Lu Shi; XiaoMin Zhou; Te Yang; MeiYin Zhang; NuoQing Weng; XinGe Zhao; RuiQi Wang; Ji Liu; Rui Sun; HaiDe Qin; HuiYun Wang
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

6.  Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis.

Authors:  Jianguo Wang; Qiang Jiang; Oluwasijibomi Damola Faleti; Chi-Man Tsang; Min Zhao; Gongfa Wu; Sai-Wah Tsao; Minyi Fu; Yuxiang Chen; Tengteng Ding; Tuotuo Chong; Yufei Long; Xu Yang; Yuanbin Zhang; Yunxi Cai; Hanzhao Li; Manli Peng; Xiaoming Lyu; Xin Li
Journal:  Mol Ther Nucleic Acids       Date:  2020-08-19       Impact factor: 8.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.